ERNA icon

Eterna Therapeutics

34 hedge funds and large institutions have $5.66M invested in Eterna Therapeutics in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

85% less capital invested

Capital invested by funds: $38.4M → $5.66M (-$32.8M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$96K
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

1 +$603K
2 +$316K
3 +$136K
4
Two Sigma Investments
Two Sigma Investments
New York
+$115K
5
Goldman Sachs
Goldman Sachs
New York
+$57.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$977K
2
$814K
3
$629K
4
$627K
5
$626K
6
$590K
7
$416K
8
$170K
9
$126K
10
$107K
11
$81K
12
$75K
13
$48K
14
$48K
15
$46K
16
$37K
17
$26K
18
$25K
19
$22K
20
$21K
21
$21K
22
$19K
23
$14K
24
$10K
25
$10K